Aditya routes capital, talent, and expertise between operators who need to find each other.
- →CISA added 24 new known-exploited vulnerabilities in August 2026
- →3 UK wealth firms hiring succession advisors this quarter
- →AI companies expanding enterprise sales teams (51 open roles across Series A–C startups)
- →FDA remediation windows opened this week (Class II device 510(k) pathway clarity updated)
Sourced from CISA KEV Catalog, SEC EDGAR, FDA warning letters, IPO calendar, and proprietary B2B signal feeds — updated as it publishes.
- $3.2M wealth transitionHNW family office → boutique wealth advisor — founder liquidity event, $120M post-sale assets, seeking advisor with tax-aware, family-office-grade positioning and governance.
- $180,000 annual managed security programMSSP → mid-market healthcare group — healthcare group, 300 employees, 60 days past a breach filing, no security staff, insurer demanding documented controls before renewal.
- $1.8M Series A deploymentAI infrastructure founder → enterprise customer prospects — AI ops platform, customer acquisition cycle 90–120 days, product-market fit proven, go-to-market still manual.
- $85,000 SOC 2 Type II programCompliance consultancy → SaaS company on a customer-mandated deadline — B2B SaaS, Series B, enterprise contract won on the condition that a Type II report lands in six months.
- $4.5M FDA regulatory strategyMedical device manufacturer → regulatory affairs firm — Class II device, 18-month commercialization timeline, existing 510(k) pathway unclear, need ops team on day one.
- $120,000 vCISO + remediation retainervCISO practice → manufacturer on an insurance-driven timeline — 400-person manufacturer whose renewal quote came back with an MFA/EDR deficiency list and a 20% loading, 80 days out.
Each side arrived with a calendar date, a problem, and nobody in-house who owned it. The match gives both a counterparty who understands the real constraint.